, 21 December 2017 (2017-12-21), Retrieved from the Internet: URL:https://www.merriam-webster.com/dictio nary/composition [retrieved on 2017-12-21] (B1)

A. ENDIMIANI ET AL: "Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 63, no. 3, 15 January 2009 (2009-01-15), pages 427-437, XP55017325, ISSN: 0305-7453, DOI: 10.1093/jac/dkn547 (B1)

CN-A- 1 565 455 (B1)

CN-A- 1 565 456 (B1)

JONES R N ET AL: "Antimicrobial spectrum of cefpirome combined with tazobactam against the Bacteroides fragilis group", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES, ELSEVIER SCIENCE PUBLISHING CO., AMSTERDAM, NL, vol. 13, no. 5, 1 September 1990 (1990-09-01), pages 371-373, XP023790076, ISSN: 0732-8893, DOI: 10.1016/0732-8893(90)90004-F [retrieved on 1990-09-01] (B1)

WO-A1-2007/086014 (B1)

US-A1- 2010 029 604 (B1)

US-A1- 2010 197 650 (B1)

VANSCOY BRIAN D ET AL.: "Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 61, no. 12, 1 December 2017 (2017-12-01), (B1)

WO-A1-2007/086011 (B1)

MACGOWAN ALASDAIR; ROGERS CHRIS; BOWKER KAREN: "In vitro models, in vivo models, and pharmacokinetics: What can we learn from in vitro models?", CLINICAL INFECTIOUS DISEASES, vol. 33, no. Suppl. 3, 15 September 2001 (2001-09-15), pages S214-S220, (B1)